Resources: Bibliography

Learn how other researchers have used our CMS data to publish papers in high-impact journals.

To access details on a specific paper, click the title.

Information icon.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Title

Summary

Author(s)

Publisher

Year

No papers found. Clear your search, and try a new search word or phrase.

Racial Disparities and Temporal Trends in Dementia Misdiagnosis Risk in the United States

Systematic disparities in misdiagnosis of dementia across racial/ethnic groups have implications for health disparities. We compared the risk of dementia under- and overdiagnosis in clinical settings across racial/ethnic groups from 2000 to 2010.

Gianattasio, K.Z., Prather, C., Glymour, M.M., Ciarleglio, A., Power, M.C.

Alzheimer's & Dementia

2019

Validation of a Claims-Based Frailty Index Against Physical Performance and Adverse Health Outcomes in the Health and Retirement Study

Background: A claims-based frailty index (CFI) was developed based on a deficit-accumulation approach using self-reported health information. This study aimed to independently validate the CFI against physical performance and adverse health outcomes.

Kim, D., Glynn, R., Avorn, J., Lipsitz, L., Rockwood, K., Pawar, A., and Schneeweiss, S.

Journals of Gerontology Series A: Biological Sciences and Medical Sciences

2019

APOE Region Molecular Signatures of Alzheimer's Disease across Races/Ethnicities

The role of even the strongest genetic risk factor for Alzheimer's disease (AD), the apolipoprotein E (APOE) e4 allele, in its etiology remains poorly understood. We examined molecular signatures of AD defined as differences in linkage disequilibrium patterns between AD-affected and -unaffected whites (2673/16,246), Hispanics (392/867), and African Americans (285/1789), separately.

Kulminski, A.M., Shu, L., Loika, Y., Nazarian, A., Arbeev, K.G., Ukraintseva, S., Yashin, A. I., Culminskaya, I.

Neurobiology of Aging

2019

Genetic Heterogeneity of Alzheimer's Disease in Subjects with and without Hypertension

Alzheimer's disease (AD) is a progressive neurodegenerative disorder caused by the interplay of multiple genetic and non-genetic factors. Hypertension is one of the AD risk factors that has been linked to underlying pathological changes like senile plaques and neurofibrillary tangles formation as well as hippocampal atrophy. In this study, we investigated the differences in the genetic architecture of AD between hypertensive and non-hypertensive subjects in four independent cohorts.

Nazarian, A., Arbeev, K.G., Yashkin, A.P., Kulminski, A.M.

GeroScience

2019

Evaluation of the Genetic Variance of Alzheimer's Disease Explained by the Disease-Associated Chromosomal Regions

Heritability analysis of complex traits/diseases is commonly performed to obtain illustrative information about the potential contribution of the genetic factors to their phenotypic variances. In this study, we investigated the narrow-sense heritability (h2) of Alzheimer's disease (AD) using genome-wide single-nucleotide polymorphisms (SNPs) data from three independent studies in the linear mixed models framework.

Nazarian, A., Kulminski, A.M.

Journal of Alzheimer's Disease

2019

Genome-Wide Analysis of Genetic Predisposition to Alzheimer's Disease and Related Sex Disparities

We investigated the genetic architecture of AD in four publicly available independent datasets through genome-wide association, transcriptome-wide association, and gene-based and pathway-based analyses. To explore differences in the genetic basis of AD between males and females, analyses were performed on three samples in each dataset: males and females combined, only males, or only females.

Nazarian, A., Yashin, A. I., Kulminski, A.M.

Alzheimer's Research & Therapy

2019

Strong Impact of Natural-Selection-Free Heterogeneity in Genetics of Age-Related Phenotypes

A conceptual difficulty in genetics of age-related phenotypes that make individuals vulnerable to disease in post-reproductive life is genetic heterogeneity attributed to an undefined role of evolution in establishing their molecular mechanisms. Here, we performed univariate and pleiotropic genome-wide meta-analyses of 20 age-related phenotypes leveraging longitudinal information in a sample of 33,431 individuals and dealing with the natural-selection-free genetic heterogeneity.

Kulminski, A.M., Huang, J., Loika, Y., Arbeev, K.G., Bagley, O., Yashkin, A., Duan, M., Culminskaya, I.

Aging

2018

Identifying Older Adults with Serious Illness: A Critical Step toward Improving the Value of Health Care.

Objective(s): To create and test three prospective, increasingly restrictive definitions of serious illness.

Kelley, A. S., Covinsky, K. E., Gorges, R. J., McKendrick, K., Bollens-Lund, E., Morrison, R. S., & Ritchie, C. S.

Health Services Research

2017

The Impact of Disability and Social Determinants of Health on Condition-Specific Readmissions beyond Medicare Risk Adjustments: A Cohort Study.

Objective(s): To assess the impact of disability and social determinants of health on condition-specific readmissions beyond current risk adjustment.

Meddings, J., Reichert, H., Smith, S. N., Iwashyna, T. J., Langa, K. M., Hofer, T. P., & McMahon, L. F.

Journal of General Internal Medicine

2017

Out-of-Pocket Spending and Financial Burden Among Medicare Beneficiaries With Cancer.

Objective(s): To measure out-of-pocket (OOP) costs incurred by Medicare beneficiaries with cancer and identify which factors and services contribute to high OOP costs.

Narang, A. K., & Nicholas, L. H.

JAMA Oncology

2017